Michele Klain

About Michele Klain

Michele Klain, With an exceptional h-index of 29 and a recent h-index of 17 (since 2020), a distinguished researcher at Università degli Studi di Napoli Federico II, specializes in the field of trattamento terapia radioiodio nei carcinomi e negli ipertiroidismi nelle patologie tiroidee.

His recent articles reflect a diverse array of research interests and contributions to the field:

Exploring the value of sentinel lymph node PET/CT detection in thyroid carcinoma

Long-axial-field of view in prostate cancer next generation imaging: the launch pad of theragnostic

New opportunities for dosimetric approach in patients with differentiated thyroid cancer

Metastatic castration-resistant prostate cancer therapy: the quest for the perfect molecule

[18F]FET PET/MR and machine learning in the evaluation of glioma

Artificial intelligence-based application in multiple myeloma

MR imaging characterization of pheochromocytoma: a comparison between typical and atypical tumor lesions

Radiofrequency ablation versus radioactive iodine: the race for the best cure

Michele Klain Information

University

Position

Dipartimento di Scienze Biomediche Avanzate

Citations(all)

3317

Citations(since 2020)

1031

Cited By

2559

hIndex(all)

29

hIndex(since 2020)

17

i10Index(all)

59

i10Index(since 2020)

34

Email

University Profile Page

Università degli Studi di Napoli Federico II

Google Scholar

View Google Scholar Profile

Michele Klain Skills & Research Interests

trattamento terapia radioiodio nei carcinomi e negli ipertiroidismi nelle patologie tiroidee

Top articles of Michele Klain

Title

Journal

Author(s)

Publication Date

Exploring the value of sentinel lymph node PET/CT detection in thyroid carcinoma

European Journal of Nuclear Medicine and Molecular Imaging

Fabio Volpe

Leandra Piscopo

Michele Klain

2024/1

Long-axial-field of view in prostate cancer next generation imaging: the launch pad of theragnostic

European Journal of Nuclear Medicine and Molecular Imaging

Fabio Volpe

Carmela Nappi

Michele Klain

2024/2/14

New opportunities for dosimetric approach in patients with differentiated thyroid cancer

European Journal of Nuclear Medicine and Molecular Imaging

Leandra Piscopo

Emilia Zampella

Michele Klain

2024/1

Metastatic castration-resistant prostate cancer therapy: the quest for the perfect molecule

European Journal of Nuclear Medicine and Molecular Imaging

Davide Bianco

Carmela Nappi

Michele Klain

2024/2

[18F]FET PET/MR and machine learning in the evaluation of glioma

European Journal of Nuclear Medicine and Molecular Imaging

Leandra Piscopo

Emilia Zampella

Michele Klain

2024/2

Artificial intelligence-based application in multiple myeloma

European Journal of Nuclear Medicine and Molecular Imaging

Leandra Piscopo

Mariano Scaglione

Michele Klain

2024/4/8

MR imaging characterization of pheochromocytoma: a comparison between typical and atypical tumor lesions

Simone Maurea

Ludovica Attanasio

Roberta Galatola

Valeria Romeo

Arnaldo Stanzione

...

2024/1/30

Radiofrequency ablation versus radioactive iodine: the race for the best cure

European Journal of Nuclear Medicine and Molecular Imaging

Fabio Volpe

Carmela Nappi

Andrea Ponsiglione

Michele Klain

2024/3/15

Tumor Burden of Iodine-Avid Bone Metastatic Thyroid Cancer Identified via 18F-Sodium Fluoride PET/CT Imaging

Journal of Clinical Medicine

Carmela Nappi

Emilia Zampella

Valeria Gaudieri

Fabio Volpe

Leandra Piscopo

...

2024/1/19

Expanding the long-axial field-of-view PET-CT horizons: unveiling new arrows in our quiver

European Journal of Nuclear Medicine and Molecular Imaging

Andrea Ponsiglione

Carmela Nappi

Fabio Volpe

Michele Klain

2024/3/4

Prognostic value of 12-month response to therapy in pediatric patients with differentiated thyroid cancer

Endocrine

Emilia Zampella

Leandra Piscopo

Mariarosaria Manganelli

Fabio Volpe

Carmela Nappi

...

2023/6

INTERNAL DOSIMETRY PROTOCOL ASSESSMENT IN PEPTIDE RECEPTOR RADIONUCLIDE THERAPY (PRRT) AT NUCLEAR MEDICINE DEPARTMENT, UNIVERSITY HOSPITAL FEDERICO II, NAPLES

Physica Medica: European Journal of Medical Physics

A Varallo

ME Italiano

V Gaudieri

M Klain

C Oliviero

...

2023/11/1

Type 2 deiodinase Thr92Ala polymorphism and aging are associated with a decreased pituitary sensitivity to thyroid hormone

Thyroid

Cristina Luongo

Maria Angela De Stefano

Raffaele Ambrosio

Fabio Volpe

Tommaso Porcelli

...

2023/3/1

Emerging role of nuclear medicine in prostate cancer: current state and future perspectives

Fabio Volpe

Carmela Nappi

Leandra Piscopo

Emilia Zampella

Ciro Gabriele Mainolfi

...

2023/9/27

Efficacy of empirical radioiodine therapy in patients with differentiated thyroid cancer and elevated serum thyroglobulin without evidence of structural disease: a propensity …

Cancers

Leandra Piscopo

Emilia Zampella

Fabio Volpe

Valeria Gaudieri

Carmela Nappi

...

2023/8/21

Alpha emitter isotopes and PSMA ligands: the near future therapeutic prospective for castration-resistant prostate cancer

Fabio Volpe

Leandra Piscopo

Emilia Zampella

Michele Klain

2023/12/23

Diagnosis, management and theragnostic approach of gastro-entero-pancreatic neuroendocrine neoplasms

Leandra Piscopo

Emilia Zampella

Sara Pellegrino

Fabio Volpe

Carmela Nappi

...

2023/7/4

Thyroid cancer radiomics: navigating challenges in a developing landscape

Simone Maurea

Arnaldo Stanzione

Michele Klain

2023/12/18

Prediction of 2-[18F]FDG PET-CT SUVmax for Adrenal Mass Characterization: A CT Radiomics Feasibility Study

Cancers

Arnaldo Stanzione

Renato Cuocolo

Claudia Bombace

Ilaria Pesce

Ciro Gabriele Mainolfi

...

2023/6/30

DOSIMETRY IN MOLECULAR RADIOTHERAPY: A TRADE-OFF BETWEEN RESEARCH AND CLINICAL PRACTICE

Physica Medica: European Journal of Medical Physics

D Bianco

V Gaudieri

F Loffredo

E Zampella

L Piscopo

...

2023/11/1

See List of Professors in Michele Klain University(Università degli Studi di Napoli Federico II)